INNOVATION KITCHEN AT IBRIDGE HUB POWERED BY BANK OF INDUSTRY PRESENTS A NEW ERA OPENING NEW POSSIBILITIES

Share

article by niran in

Opportunity To Partner When You’re A Startup The number of new startups is rapidly increasing. While that’s great news for the overall economy, for new entrepreneurs it means more competition for media attention, investors, and customers. One option for startups is to partner with other companies and people with complimentary skills  in order to have a greater sense of stability as the new company grows. But how do you get the attention and convince them to join force...

Opportunity To Partner When You’re A Startup

The number of new startups is rapidly increasing. While that’s great news for the overall economy, for new entrepreneurs it means more competition for media attention, investors, and customers.

One option for startups is to partner with other companies and people with complimentary skills  in order to have a greater sense of stability as the new company grows. But how do you get the attention and convince them to join forces with you?

These partnership can create a unique relationships that can allow both sides to achieve their goals. But know the process is not easy and should not be entered into blindly. 

Here are five steps to take to successfully partner your startup with others: 

1. Define what you want out of a partnership

Creating a partnership just for the sake of collaborating will be a waste of time. You need to have a good sense of what you want the end results of any partnership to be.It is absolutely necessary that any organization you choose to partner with shares the  same goal. 

Before you even begin looking for a company to partner with, think about what yourstartup could do better. Is distribution weak? Does the product design need tweaking? Are you having trouble reaching the demographic you’d like to target?

2. Know what you bring to the table

A great relationship is a balance of give and take. When you approach a potentialpartner, don’t bother contacting them unless you know why they would want to speak with you. Know what you have to offer them.

Chances are your startup was born from a problem. You saw an issue or something that was missing and developed a solution. If another organization is going to get involved, you need to find a way your solution helps them, too.

3. Find a personal contact at the larger company

Sometimes cold pitching works, begin by building a relationship, constantly be alert for signs that indicate what it will be like to work as a team. Consider the core values of your startup company and whether or not this relationship will allow you to stay true to them.

Be transparent about your intentions and listen to each other, until this new connection strengthened. When both sides were ready to do business together, there was already a solid foundation in place.

4. Make sure goals align

As you embark on any undertaking with a new partner, it’s important to be upfront and honest about each other’s expectations for the project. Get on the same page about everything from each company‘s roles and responsibilities to how you’ll evaluate success.

5. Be patient

As an entrepreneur, it can be frustrating to constantly be waiting for your partner to get back to you with their decision. But realize that, from their perspective, it can be equally annoying to feel rushed.

Establish deadlines and modes of communication that both sides are comfortable with and be understanding when red tape occasionally slows things down.

Partnering with a larger company isn’t right for every startup. It takes a hard work and collaboration, as well as a lot of patience! However, teaming up with a more established company can be a huge win if you get it right.

We at Innovation Kitchen NG believe in these principles and it’s exactly what we are set up to encourage and provide help for at this time.

You need partners to help you serve the greater good by pivoting and adapting yourself business or organization, leveraging technology for our common good, growth and development not just to survive but thrive in this post Covid 19 world.

This is our invitation to you but we understand it’s not for everyone but if it’s you then please go through this write up to find where you fit.

Looking forward to working with you and making an impact through innovation. Then write your own story! Kindly reach out to us today if you are interested to be part of this unique opportunity and time

Details of on going projects here: https://drive.google.com/file/d/1kTHp4oxIdOiq4QtOkFTiqYxpCXrwSRhs/view?usp=drivesdk  & pdf attached 
 
Best regards


Francis Madojemu
Founder Innovation Kitchen NG

Send an Email to
innovationkitchenng@gmail.com  
info@innovationkitchen.com.ng
Call/Whatsapp
+2348023182881
 
See our official brochures below:

Innovation Kitchen consultancy Brochure

Innovation Kitchen Brochure


Adapted from How to partner with a larger company when you’re a startup
Aaron Michel. https://thenextweb.com/entrepreneur/2016/02/14/how-to-partner-with-a-larger-company-when-youre-a-startup/

View 85 0
4 months ago

Covid-19 Pivot Support & Adapting Today in Service of a New Future in Your Community

Share

article by niran in

Business as usual was out the window. We needed to establish a new normal and we needed to do it now. But how? To adapt effectively you need to have two things:  1. A willingness to adapt, to change and pivot - not only your strategy but in some cases your end goal and  2. An awareness of external factors. Big Ideas: * Adapt & Adopt Before Pivot * During, After and the future of business * Minor To Major, Big To Small * Creating Ethical Opportunity From Struggle Do N...

Business as usual was out the window. We needed to establish a new normal and we needed to do it now. But how?

To adapt effectively you need to have two things: 
1. A willingness to adapt, to change and pivot - not only your strategy but in some cases your end goal and 
2. An awareness of external factors.

Big Ideas:
* Adapt & Adopt Before Pivot
* During, After and the future of business
* Minor To Major, Big To Small
* Creating Ethical Opportunity From Struggle

Do NOT do this ALONE. Let third-party experts help you make hard decisions to plan for an immediate response and then manage into the future. 

This isn’t just an economic decision, it’s personal for most business owners and entrepreneurs.

Fill the form below and let’s start work with your organisation NOW!
https://forms.gle/6zVvhdPD2xM5yj7Z6

InnovationKitchen.com.ng 

Pdf Brochure 

https://drive.google.com/file/d/1haA4ljesSLr1PSCP5GcJuUNRrMcNxf51/view?usp=drivesdk

View 99 0
5 months ago

FDA Says Hydroxychloroquine and Chloroquine Can Be Used to Treat Coronavirus By Kashmira Gander On 3/30/20 at 4:12 AM EDT

Share

article by niran in

The U.S. Food and Drug Administration (FDA) has approved the use of two anti-malaria drugs to treat patients infected by the new coronavirus. On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization. (EUA) That marked the first EUA for a drug...

The U.S. Food and Drug Administration (FDA) has approved the use of two anti-malaria drugs to treat patients infected by the new coronavirus.

On Sunday, the U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization. (EUA) That marked the first EUA for a drug related to COVID-19 in the U.S., according to the statement.

Currently, there are no specific drugs for COVID-19 which, as shown in the Statista graph below (accurate as of March 26), has sickened over half a million people. According to Johns Hopkins University, over 720,000 cases have been confirmed, more than 34,000 people have died, and over 152,000 have recovered since the pandemic started in China late last year.

 

 

Both chloroquine and hydroxychloroquine are used to treat diseases including malaria, and have "shown activity in laboratory studies against coronaviruses, including SARS-CoV-2 (the virus that causes COVID-19)," the HHS stated.

"Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients. Clinical trials are needed to provide scientific evidence that these treatments are effective."

Under the EUA, health care providers and patients must be given fact sheets outlining the known risks and drug interactions of the medications. The HSS said it accepted 30 million doses of hydroxychloroquine sulfate from an arm of the pharmaceutical company Novartis, and one million of chloroquine phosphate from Bayer Pharmaceuticals to be used for treating hospitalized COVID-19 patients or in clinical trials.

"These and other companies may donate additional doses, and companies have ramped up production to provide additional supplies of the medication to the commercial market," the HHS said. "Given the importance of understanding the efficacy of these medications for the treatment and prevention of COVID-19, federal agencies, such as the National Institutes of Health and ASPR's Biomedical Advanced Research and Development Authority (BARDA), are working together to plan clinical trials.

" The Strategic National Stockpile will ship the drugs to states, according to the statement. The HHS said it hoped the donated drugs would "ease supply pressures" for the medications, and that it was working with manufacturers to boost production to ensure those who depend on them to treat conditions such as malaria, lupus, and rheumatoid arthritis have access. The decision comes after FDA commissioner Stephen Hahn said that the agency would "take a closer look" at chloroquine in "a large pragmatic clinical trial—to actually gather that information and answer that question that needs to be asked and answered," after President Donald Trump said chloroquine and hydroxychloroquine showed promise in COVID-19 patients.

 

 

Last week, the authors of a paper published in the Journal of Zhejiang University concluded that hydroxychloroquine is no better a treatment for coronavirus than currently used methods.

Vineet Menachery, Assistant Professor in the Department of Microbiology & Immunology at the University of Texas Medical Branch who was not involved in the research, cautioned to Newsweek last week that the paper involved a small number of participants. And while the patients didn't improve and it doesn't appear to worsen COVID-19, there are concerns about its side effects.

He told Newsweek: "Like the papers to date on hydroxychloroquine and chloroquine, there isn't much concrete data." As experts investigate the potential benefits of the drugs, health officials last week urged members of the public not to selfmedicate, after an Arizona man who took chloroquine phosphate in the form of a fish tank cleaner died.

Ian Hall, professor of molecular medicine at the University of Nottingham told Newsweek: "I am slightly surprised by this approach, as at present we don't know if these drugs are effective. Whilst there is some laboratory work and also anecdotal evidence in patients they may be effective, there are also preliminary trial data suggesting they may not work.

"All drugs have potential side effects, and we obviously want to avoid side effects in patients who are already ill with COVID19. Hence in my view the most important thing to do is to undertake formal clinical trials to find out if there is a role for these drugs in the management of different groups of patients with COVID-19."

Hall said: "Ultimately we hope a vaccine will be available, and initial studies have already commenced in healthy volunteers, but it is likely to be at least six months before we may have a vaccine for wider use."

Robin May, professor of infectious diseases and director of the Institute of Microbiology and Infection at the U.K.'s University of Birmingham, told Newsweek: "Like many things about this pandemic, the decision regarding chloroquine is a very tough one to make. Early data showed promising results with this drug, but a more recent study from China showed no evidence of efficacy. Both studies are very small, though, so the jury is still very much out.

"What is very much needed at this stage is a randomized clinical trial to establish efficacy of chloroquine—but of course, this is a challenging and long-term undertaking. In the meantime, the FDA has approved the drug for situations where alternatives are not available.

" May continued: "It is critical to emphasize, however, that chloroquine can have substantial side effects, particularly if the dosing is not correct.

"The individual risk/benefit will be something that clinicians will take into account on a patient by patient basis and consequently it is absolutely essential that patients do not self-medicate in the meantime, which can have life-threatening consequences.

" Andrew Preston, reader in microbial pathogenesis at the U.K.'s University of Bath, told Newsweek there is a sound basis for the use of the drugs, and the anti-viral effects of chloroquine have been demonstrated in a number of laboratory studies involving the close relatives of SARS-CoV-2—the SARS and MERS viruses.

"However, while providing a rationale for the FDA decision, laboratory tests on isolated cells are a long way from showing efficacy in patients," he said.

Preston explained clinical trials "involve numbers of study participants (patients in this case) of the appropriate size to given statistically significant results." The participants are randomly assigned the treatment or a control "in which the two groups are well matched for as many parameters as possible." Those might include age, gender, underlying conditions, study centers like hospitals where precise care may differ, days since onset of symptoms, and medications taken.

Such steps haven't been followed when it comes to using chloroquine or hydroxychloroquine in COVID-19 patients, he said, and therefore it has not been possible to properly determine whether either drug had an effect, or not.

"Unfortunately, proper clinical trials take time to set up and to conduct. A number are already underway, and initial results from these can be expected in the coming days and weeks," said Preston.

Fortunately, both drugs have been used in humans, meaning doctors know they are well-tolerated, as well as the side effects and appropriate dosing levels.

"Thus, the huge concerns regarding patient safety are lifted in terms of using chloroquine and hydroxychloroquine," he said. "In this regard, many will see it as a case of 'can do no harm, but might do some good' and combined with the relative cheapness of the drugs, this probably contributed to the FDA's decision.

" Preston said: "The desperate clinical need for treatment options for COVID-19, and the pressure that authorities are under to provide answers/solutions, and to be shown to providing them, it is perhaps understandable as to why the FDA has moved to approve chloroquine and hydroxychloroquine use, before the firm evidence supporting their use is available.

" This article has been updated with comment from Professor Ian Hall, Professor Robin May, and Andrew Preston.

World Health Organization advice for avoiding spread of coronavirus disease (COVID-19) Hygiene advice

Clean hands frequently with soap and water, or alcohol-based hand rub.

Wash hands after coughing or sneezing; when caring for the sick; before, during and after food preparation; before eating; after using the toilet; when hands are visibly dirty; and after handling animals or waste.

Maintain at least 1 meter (3 feet) distance from anyone who is coughing or sneezing.

Avoid touching your hands, nose and mouth.

Do not spit in public.

Cover your mouth and nose with a tissue or bent elbow when coughing or sneezing.

Discard the tissue immediately and clean your hands.

 

Medical advice

Avoid close contact with others if you have any symptoms.

Stay at home if you feel unwell, even with mild symptoms such as headache and runny nose, to avoid potential spread of the disease to medical facilities and other people.

If you develop serious symptoms (fever, cough, difficulty breathing) seek medical care early and contact local health authorities in advance.

Note any recent contact with others and travel details to provide to authorities who can trace and prevent spread of the disease.

Stay up to date on COVID-19 developments issued by health authorities and follow their guidance.

Mask and glove usage

Healthy individuals only need to wear a mask if taking care of a sick person.

Wear a mask if you are coughing or sneezing.

Masks are effective when used in combination with frequent hand cleaning.

Do not touch the mask while wearing it.

Clean hands if you touch the mask.

Learn how to properly put on, remove and dispose of masks.

Clean hands after disposing of the mask.

Do not reuse single-use masks.

Regularly washing bare hands is more effective against catching COVID-19 than wearing rubber gloves.

The COVID-19 virus can still be picked up on rubber gloves and transmitted by touching your face.

 

https://www.newsweek.com/fda-says-hydroxychloroquine-chloroquine-can-used-treat-coronavirus-1494925 

View 102 0
6 months ago

Dr. On Malaria Drug: ‘Absolute Game Changer,’ ‘Beginning Of The End Of The Pandemic’ Ryan Saavedra April 2nd, 2020

Share

article by niran in

An infectious disease doctor told Fox News on Wednesday night that using hydroxychloroquine and azithromycin to treat patients that have the coronavirus was an “absolute game changer” and that it was “the beginning of the end of the pandemic.” Appearing on Fox News’ “The Ingraham Angle” with host Laura Ingraham, Dr. Stephen Smith explained why he believes that the regimen has been effective for treating his patients. Smith began by explaining what bei...

An infectious disease doctor told Fox News on Wednesday night that using hydroxychloroquine and azithromycin to treat patients that have the coronavirus was an “absolute game changer” and that it was “the beginning of the end of the pandemic.”

Appearing on Fox News’ “The Ingraham Angle” with host Laura Ingraham, Dr. Stephen Smith explained why he believes that the regimen has been effective for treating his patients. Smith began by explaining what being “intubated” meant, saying it “actually means putting a tube down your trachea and then placed on the ventilator for support, respiratory support.”

“We’ve had, I mentioned 20 intubations, most all of them occurred in the first two days,” Smith continued. “More importantly, no person who has received five days or more of the hydroxychloroquineazithromycin combination has been intubated. The chance of that occurring by chance, according to my sons who did some stats for me, are .000 something.”

“It’s a ridiculous low no matter how you look at it,” Smith continued.

“We worry about selection bias in the situation, but I cannot think of a reason why, if all else is equal, why people that have received five days or more — even four days or more of this hydroxychloroquineazithromycin regimen wouldn’t get intubated.”

When asked by Ingraham if it was a game changer, Smith responded, “It’s a game changer. It’s an absolute game changer. I think this data will go to really support the French data. Now you actually have an intra[inaudible] comparison saying that this regimen works and I will get some real statisticians besides my sons to look at that.”

“I think this is the beginning of the end of the pandemic,” Smith said. “I’m very serious.” WATCH: The New York Times reported on Wednesday that “the malaria drug hydroxychloroquine helped to speed the recovery of a small number of patients who were mildly ill from the coronavirus, doctors in China reported this week.”

“Cough, fever and pneumonia went away faster, and the disease seemed less likely to turn severe in people who received hydroxychloroquine than in a comparison group not given the drug,” the Times added. “Previous reports from China and France that the drug seemed to help patients, along with enthusiastic comments from President Trump, have created a buzz around hydroxychloroquine and the closely related chloroquine, which are decades-old drugs used to treat malaria and autoimmune diseases like lupus and rheumatoid arthritis.”

The Times noted that experts had said that more testing and research was needed on using the treatment to treat the coronavirus but that initial results were promising. “It’s going to send a ripple of excitement out through the treating community,” said Dr. William Schaffner, an infectious disease expert at Vanderbilt University.

“I think it will reinforce the inclination of many people across the country who are not in a position to enter their patients into clinical trials but have already begun using hydroxychloroquine.”

The Times notes that Dr. Schaffner “cautioned that the results applied only to patients with relatively mild illness, like the ones in the study, and could not be generalized to advanced cases.” The treatment has been touted by President Trump, and members of the administration’s Coronavirus Task Force have remained positive about its potential use to treat coronavirus patients.

Source: https://www.dailywire.com/news/dr-on-malaria-drug-absolute-game-changer-beginning-of-the-end-of-the-pandemic

View 117 0
6 months ago

We Need Masks for All

Share

article by niran in

We Need Masks for All #Masks4All In 1918, the Spanish Flu claimed over 50million lives. Unfortunately, it was very late in it's spread it was realized that wearing masks minimized the spread. Then they made people wear masks at gun point.    We should not deplete surgical masks and wear masks indefinitely.  But there is a number of weeks in the pattern of the pandemic that DIY masks can help reduce the spread (note the emphasis is not on personal protection alon...

We Need Masks for All

#Masks4All

In 1918, the Spanish Flu claimed over 50million lives. Unfortunately, it was very late in it's spread it was realized that wearing masks minimized the spread. Then they made people wear masks at gun point. 

 

We should not deplete surgical masks and wear masks indefinitely. 

But there is a number of weeks in the pattern of the pandemic that DIY masks can help reduce the spread (note the emphasis is not on personal protection alone). If we can slow things down, we can keep our healthcare and economic systems from collapse.

 

With our depleted health care systems, our financial situation with the price of oil and the economy in dire straits and having no record of remarkable or distinguished leadership in our current history. We cannot depend on government or our medical systems even made more challenging with the level of public awareness and education on these matters 

 

We must find simple cost effective yet efficient systems and processes that everyone can do or contribute to in order to stem the tide of the growth of this coronavirus and more importantly safely go back to work before the cure becomes more expensive than the sickness and we damage it beyond our ability to bounce back.

 

I am asking you, really, begging you to help us and our nation to supply our population with #masks4all to be used in public spaces to contain the spread of this virus. We are looking for takers, philanthropists, selfless citizens, entrepreneurs and you and I to get involved in any or all of our 3 prong approach to stopping this virus in addition to the already implemented and recommend policies already in place.

 

We need help to manufacture locally masks that can be used to prevent the spread using every possible resource at our disposal for millions of people. We need to creatively and innovative educate the public about the virus and the current strategy as well as healthy use of masks in public places to curb the spread. Finally we must keep records and track the effectiveness of this strategy working with others to measure its efficacy.

 

Every little helps even the production, distribution and measured impact of one mask to one person or masks to a family would cut down on the ability to infect others which we know grows exponentially. This means every single one of us can make a difference and many even more.

 

We can do this and lead our continent out of this nightmare and predictions of the world system but we must do this together everyone making a sacrifice for another. We can only promise to recognize and award those who have astounding impact and ideas that scale 

 

To register click here

 

https://forms.gle/ZkyxUSgztpyQATtV6 

#innovationkitchenNG

#Mask4all

#Covid-19

Brochure Link: https://drive.google.com/file/d/1LVPm-Prnd-4pxcpZR7lFTt_uDPsnstSD/view?usp=drivesdk

 

Thank you & God bless 

View 99 0
6 months ago

Custom

Share

Product by Ayoola Falola in

Perfect for Start-ups and Businesses with small budgets Discovery & Consultant Tailor-made research Revision, Design & Timeline Specially Designed Training (Includes Staff) Prototype Management Fund-raising & Finance Market-test & data Follow-up & Monitoring Project-based pricing

Perfect for Start-ups and Businesses with small budgets

  • Discovery & Consultant
  • Tailor-made research
  • Revision, Design & Timeline
  • Specially Designed Training (Includes Staff)
  • Prototype Management
  • Fund-raising & Finance
  • Market-test & data
  • Follow-up & Monitoring
  • Project-based pricing
View 89 0
6 months ago
Next →